BridgeMD
New treatment option for Phantom Limb Pain
Official title Treatment of Phantom Limb Pain by Intensive Visual Simulation Therapy
ClinicalTrials.gov ID: NCT06483035
What this study is testing
- What it's testing
- Phantom limb pain (PLP) is reported by as much as 80 % of patients following an amputation. There is increasing knowledge of the relation between PLP and maladaptive changes in brain cortical regions.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Unilateral or bilateral lower limb/upper limb amputees
- Adults \> 18 years of age, no age limit
- A minimum of 12 months since amputation
- Chronic PLP: \> 6 months
- PLP intensity: \> 3 on the 0-10 VAS scale
You likely can't join if
- Significant visual impairment / blind
- Unable to follow instructions, i.e significant cognitive impairment.
See the full eligibility criteria
- Unilateral or bilateral lower limb/upper limb amputees
- Adults \> 18 years of age, no age limit
- A minimum of 12 months since amputation
- Chronic PLP: \> 6 months
- PLP intensity: \> 3 on the 0-10 VAS scale
- Analgesic treatments must have been stable for the previous month
- Stable prosthetic situation (ie, satisfaction with the fitting of the prosthesis) or being a non-user.
- Adequate Norwegian language skills
- Significant visual impairment / blind
- Unable to follow instructions, i.e significant cognitive impairment.
The study team makes the final eligibility decision.
Where it's taking place
- Oslo, Norway
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oslo, Norway. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.